Cognition Therapeutics Stock (NASDAQ: CGTX) stock price, news, charts, stock research, profile.
Open | $1.810 |
Close | - |
Volume / Avg. | 88.173K / 209.665K |
Day Range | 1.780 - 1.850 |
52 Wk Range | 0.900 - 3.490 |
Market Cap | $70.200M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 0.36% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cognition Therapeutics (NASDAQ: CGTX) through any online brokerage.
Other companies in Cognition Therapeutics’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Cara Therapeutics (NASDAQ:CARA).
The latest price target for Cognition Therapeutics (NASDAQ: CGTX) was reported by Oppenheimer on Wednesday, March 27, 2024. The analyst firm set a price target for 9.00 expecting CGTX to rise to within 12 months (a possible 373.68% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Cognition Therapeutics (NASDAQ: CGTX) is $1.9 last updated March 27, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Cognition Therapeutics.
Cognition Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Cognition Therapeutics.
Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.